ATE292679T1 - Methode zur inaktivierung von tse - Google Patents

Methode zur inaktivierung von tse

Info

Publication number
ATE292679T1
ATE292679T1 AT02726996T AT02726996T ATE292679T1 AT E292679 T1 ATE292679 T1 AT E292679T1 AT 02726996 T AT02726996 T AT 02726996T AT 02726996 T AT02726996 T AT 02726996T AT E292679 T1 ATE292679 T1 AT E292679T1
Authority
AT
Austria
Prior art keywords
tse
inactivation
infected
sample
prion
Prior art date
Application number
AT02726996T
Other languages
English (en)
Inventor
Neil D H Raven
Original Assignee
Health Prot Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26245535&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE292679(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0100420A external-priority patent/GB0100420D0/en
Priority claimed from GB0104696A external-priority patent/GB0104696D0/en
Application filed by Health Prot Agency filed Critical Health Prot Agency
Application granted granted Critical
Publication of ATE292679T1 publication Critical patent/ATE292679T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/22—Phase substances, e.g. smokes or aerosols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/015—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/02—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air by heating or combustion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2872—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against prion molecules, e.g. CD230
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38618—Protease or amylase in liquid compositions only
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Enzymes And Modification Thereof (AREA)
AT02726996T 2001-01-08 2002-01-08 Methode zur inaktivierung von tse ATE292679T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0100420A GB0100420D0 (en) 2001-01-08 2001-01-08 Degradation of TSE and similar agents
GB0104696A GB0104696D0 (en) 2001-02-26 2001-02-26 Degradation of tse and similar agents
PCT/GB2002/000052 WO2002053723A2 (en) 2001-01-08 2002-01-08 Degradation and detection of tse infectivity

Publications (1)

Publication Number Publication Date
ATE292679T1 true ATE292679T1 (de) 2005-04-15

Family

ID=26245535

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02726996T ATE292679T1 (de) 2001-01-08 2002-01-08 Methode zur inaktivierung von tse

Country Status (9)

Country Link
EP (2) EP1360282B1 (de)
JP (2) JP4427252B2 (de)
AT (1) ATE292679T1 (de)
AU (1) AU2002219336C1 (de)
CA (1) CA2434129A1 (de)
DE (1) DE60203599T2 (de)
ES (1) ES2237675T3 (de)
PT (1) PT1360282E (de)
WO (1) WO2002053723A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7303907B2 (en) 2001-01-08 2007-12-04 Health Protection Agency Degradation and detection of TSE infectivity
AUPR293801A0 (en) * 2001-02-07 2001-03-01 Novapharm Research (Australia) Pty Ltd Prion disinfection
AU2002320045B2 (en) 2001-05-31 2008-05-08 Adlyfe, Inc. Misfolded protein sensor method
DE10203225A1 (de) 2002-01-28 2003-07-31 Weigert Chem Fab Reinigung chirurgischer Instrumente
JP4521516B2 (ja) 2002-10-24 2010-08-11 明治製菓株式会社 難分解性タンパク質を分解する方法
WO2004039418A1 (en) * 2002-11-01 2004-05-13 Medical Research Council Prion decontamination
GB2394663B (en) * 2002-11-01 2006-07-12 Medical Res Council Prion decontamination
GB0406427D0 (en) 2004-03-22 2004-04-21 Health Prot Agency Biological indicator
ATE528649T1 (de) * 2005-02-15 2011-10-15 Adlyfe Inc Verfahren zum nachweis falsch gefalteter proteine und prionen
WO2008057293A2 (en) 2006-10-27 2008-05-15 E. I. Du Pont De Nemours And Company Methods and compositions for prion decontamination
US7922970B2 (en) * 2007-04-03 2011-04-12 Kimberly-Clark Worldwide, Inc. Use of sonication to eliminate prions
US8293174B2 (en) 2007-10-17 2012-10-23 American Sterilizer Company Prion deactivating composition and methods of using same
WO2010021375A1 (ja) * 2008-08-22 2010-02-25 国立大学法人大阪大学 プロテアーゼの製造方法、並びにプロテアーゼ溶液およびプロテアーゼのプロ体溶液
EP2403871A4 (de) * 2009-03-02 2013-01-16 Univ British Columbia Für missgefaltetes prionenprotein spezifische antikörper und epitope
EP2311323B1 (de) * 2009-10-19 2013-01-16 Univerza v Ljubljani Abbaumethoden von Proteinablagerungen und Prionen
EP3436085A4 (de) 2016-03-29 2020-07-29 Oneighty°C Technologies Corporation Verfahren zur schnellen bestimmung einer effektiven sterilisation, deimmunisierung und/oder desinfektion

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3042860A1 (de) * 1980-11-13 1982-06-09 Heyl & Co Chemisch-Pharmazeutische Fabrik, 1000 Berlin Kollagenpraeparate, verfahren zu ihrer herstellung und ihre verwendung in der human- und veterinaermedizin
US4614549A (en) * 1983-10-24 1986-09-30 Bausch & Lomb Incorporated Method for enzymatic cleaning and disinfecting contact lenses
US5223166A (en) * 1986-11-17 1993-06-29 Henkel Kommanditgesellschaft Auf Aktien Preparations and processes for cleaning and disinfecting endoscopes
DE3816734A1 (de) * 1988-05-17 1989-11-30 Henkel Kgaa Verfahren zur reinigung und desinfektion von hitze- und korrosionsempfindlichen medizinischen geraeten, insbesondere von endoskopen und mittel zur durchfuehrung des verfahrens
DK0730024T3 (da) * 1995-03-01 2000-04-25 Weigert Chem Fab Rensemiddel til kirurgiske instrumenter
DE69704929T2 (de) * 1996-01-29 2002-10-31 Diagnocure Inc., Ste-Foy Prionen-freies kollagen und von kollagen abgeleitete produkte und implantate für verschiedene biomedizinische anwendungen und methoden für ihre herstellung.
DE19730132C2 (de) * 1997-07-14 2000-01-20 Fraunhofer Ges Forschung Verfahren zum Nachweis von Prionen sowie eine Vorrichtung hierzu
US20020192731A1 (en) * 2001-04-12 2002-12-19 H. Shih Jason C. Method and composition for sterilizing surgical instruments
EP1251138B1 (de) * 2001-04-19 2006-07-26 Hermann Dr. Schätzl Prion Proteindimere für Impfungen

Also Published As

Publication number Publication date
ES2237675T3 (es) 2005-08-01
JP2004516845A (ja) 2004-06-10
EP1577382A2 (de) 2005-09-21
HK1057062A1 (en) 2004-03-12
JP4427252B2 (ja) 2010-03-03
EP1360282A2 (de) 2003-11-12
WO2002053723A3 (en) 2002-12-12
EP1577382A3 (de) 2006-08-30
PT1360282E (pt) 2005-06-30
WO2002053723B1 (en) 2003-02-13
CA2434129A1 (en) 2002-07-11
AU2002219336C1 (en) 2008-08-14
JP2008174568A (ja) 2008-07-31
DE60203599D1 (de) 2005-05-12
WO2002053723A2 (en) 2002-07-11
EP1360282B1 (de) 2005-04-06
AU2002219336B2 (en) 2005-04-14
JP4427587B2 (ja) 2010-03-10
DE60203599T2 (de) 2006-01-19

Similar Documents

Publication Publication Date Title
ATE292679T1 (de) Methode zur inaktivierung von tse
ATE466659T1 (de) Probenahmesystem mit phosphataseinhibitor
DE50113548D1 (de) Verfahren zum Nachweis von Influenza A/B-Viren in Speichel
ATE432358T1 (de) Kolorimetrische substrate, kolorimetrische sensoren und verwendungsverfahren
ATE412774T1 (de) Parallele genotypisierung mehrerer patientenproben
ATE554385T1 (de) Verfahren zur selektiven untersuchung von adiponectin-multimeren
ATE432470T1 (de) Verfahren zur unterscheidung des reizkolons von der entzündlichen darmerkrankung (inflammatory bowel disease, ibd) und zur überwachung von patienten mit ibd unter verwendung von endogenem gesamt-lactoferrin als marker
CY1112423T1 (el) Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης
PL2016421T3 (pl) Odczynniki i sposoby przy wykrywaniu białka barwnikami i dekstrynami
CY1108079T1 (el) Μeθοδος καθαρισμοy μεσοτριoνης
ATE437960T1 (de) Hämatologisches bestimmungsverfahren und kit
ATE418072T1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
NO20006109L (no) Analytisk metode som benytter multippel virusmerking
DE60331857D1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
ATE493432T1 (de) Gewinnung von hitzeschockproteinen
BR0317472A (pt) Sensor colorimétrico e método para detectar um analito, kit descartável para detectar a presença de um analito, método para detectar a presença de bactérias, e, artigo médico
DE60137748D1 (de) Analysesystem zur Feststellung der Stickstoffkonzentration mit hoher Genauigkeit
DE59914955D1 (de) Multiküvettenrotor
ES2171913T3 (es) Procedimiento de puesta en evidencia de contaminantes microbiologicos vivos en una muestra de producto de uso alimentario.
ATE354681T1 (de) Nachweis des virus der viralen rinderdiarrhoe in gewebsproben
DE602005017790D1 (de) Rt-pcr-verfahren zum quantitativen nachweis von hdv
DE602006015702D1 (de) Unterscheidung zwischen baktiereller meningitis und viraler meningitis
EP1613204A4 (de) Beurteilung von nervenschäden anhand von blutproben
DE60225168D1 (de) Verfahren zur auswahl bioaktiver wirkstoffe durch lumineszenzkopplung und lebendes zellensystem dafür
Adamek et al. A FRET-based assay for the discovery of West Nile Virus NS2B-NS3 protease inhibitors

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1360282

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee
RZN Patent revoked